• About Us
  • Our Editorial Policy
  • Business Directory
  • Advertise with Us
  • Our Advertisers
  • Contact Us
Australia India News
  • Alluring India - Brisbane Banner
India News Australia
  • Home
  • Current Issue
    Past Issue
  • India News
  • Politics
  • Business
  • World
    World This Week
  • Community News
  • What's On
  • Others
    Yoga in Australia News COVID-19 Community News Naari IPL News Health Travel Entertainment
  • Migrants Expo
  • National Events
  • Please wait..
Business and Trade news

Indian stock market opens higher as RBI MPC begins

  • BY India News Newsdesk
  • September 29, 2025
  • 0 COMMENTS

Mumbai, Sep 29 (IANS) The Indian equity indices opened higher on Monday with a rise in heavyweight stocks, as the key RBI MPC meeting began to decide on the repo rate.

At 9.22 am, Sensex was up 108 points or 0.14 per cent at 80,534 and Nifty was up 30 points or 0.12 per cent at 24,685.

Buying was seen in the midcap and smallcap stocks. Nifty midcap 100 index was up 302 points or 0.54 per cent at 56,680 and Nifty smallcap 100 index was up 90 points or 0.51 per cent at 17,651.

Among the sectoral indices Auto, IT, PSU bank, pharma, metal, realty and energy were major gainers. FMCG and private bank were major losers.

In the Sensex pack, BEL, Eternal, Titan, Tata Steel, Trent, M&M, Tata Motors, Infosys, Sun Pharma, TCS, SBI and Power Grid were major gainers. HUL, Axis Bank, L&T, Maruti Suzuki, Bharti Airtel, ITC and HCL Tech were major losers.

The three-day Reserve Bank of India’s Monetary Policy Committee (MPC) meeting began on Monday, and was widely expected to hold its key policy rate at 5.50 per cent.

According to analysts, the monetary policy expected on October 1 is unlikely to surprise.

The present growth-inflation dynamics do not warrant a rate cut. Therefore, the RBI is likely to hold rates while sending a dovish message to support the growth momentum in the economy, they added.

Also, the weakness in the broader market is likely to sustain given the valuations which continue to remain elevated. Investors can slowly accumulate largecaps in automobiles, banking, telecom, capital goods and cement.

“Weakness in pharmaceuticals is an opportunity to buy into the segment since India’s generic exports will not be impacted by Trump’s tariffs on patented and branded medicines,” they added.

Meanwhile, foreign institutional investors (FIIs) extended their selling streak for the fifth consecutive session on September 26, offloading equities worth Rs 5,687 crore. Domestic institutional investors (DIIs), on the other hand, absorbed the selling pressure, purchasing equities worth Rs 5,843 crore on the same day.

–IANS

avs/na

Post navigation

Samsung Heavy Industries to boost shipbuilding efforts in India
Salman Agha accuses India of ‘disrespecting cricket’ over handshake snub

Related Post

India AI Mission launches video story generating AI model
June 13, 2026
Sri Lanka’s new govt struggles with structural dependency on Chinese capital: Report
June 12, 2026
Sri Lanka’s new govt struggles with structural dependency on Chinese capital: Report
June 12, 2026
India’s inflation less of an immediate policy concern: Economists
June 12, 2026

Our Current Issue

Alluring India 2026

Alluring India 2026

Our Advertisers

  • Battery Rebate australia
  • Bess Australia Solar Panels
  • Alluring India - Brisbane 2026

Follow Us

  • facebook
  • facebook
  • facebook
  • facebook
INDIA NEWS on YouTube in Australia, bring to our readers and subscribers national and international news, editorials, expert columns, community activities and interviews of political leaders, celebrities, business professionals, academics and sport personalities among others.
  • facebook
  • facebook
  • facebook
  • facebook

Category

  • Accident
  • Adani Australia
  • Advertorial
  • Arts & Culture
  • Ashes 2022
  • Australia

Recent News

  • Kerala HC hands over probe into 23...
  • Number of rebel MPs going to increase,...

Subscribe Newsletter

Get the latest creative news from india news

  • Privacy Policy
  • Disclaimer